You just read:

Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur™, Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)

News provided by

Arbor Pharmaceuticals LLC

Jun 30, 2017, 08:00 ET